Singapore markets open in 8 hours 49 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,016.04 -55.59 (-1.10%) Dow
37,886.57 -574.35 (-1.49%) Nasdaq
15,471.78 -240.97 (-1.53%) Bitcoin USD
64,144.40 -699.43 (-1.08%) CMC Crypto 200
1,387.46 +4.89 (+0.35%)
Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 12:10PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 372.05M |
| Enterprise value | 596.57M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.29 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 2.55 |
| Enterprise value/EBITDA | -2.05 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.09 |
| 52-week change 3 | -88.68% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 37.9800 |
| 52-week low 3 | 3.2350 |
| 50-day moving average 3 | 5.0818 |
| 200-day moving average 3 | 10.2021 |
Share statistics
| Avg vol (3-month) 3 | 1.8M |
| Avg vol (10-day) 3 | 1.82M |
| Shares outstanding 5 | 104.22M |
| Implied shares outstanding 6 | 104.22M |
| Float 8 | 70.71M |
| % held by insiders 1 | 8.47% |
| % held by institutions 1 | 76.20% |
| Shares short (15 Apr 2024) 4 | 11.63M |
| Short ratio (15 Apr 2024) 4 | 7.55 |
| Short % of float (15 Apr 2024) 4 | 12.81% |
| Short % of shares outstanding (15 Apr 2024) 4 | 11.16% |
| Shares short (prior month 15 Mar 2024) 4 | 10.87M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -138.43% |
| Operating margin (ttm) | -73.19% |
Management effectiveness
| Return on assets (ttm) | -26.02% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 234.04M |
| Revenue per share (ttm) | 2.77 |
| Quarterly revenue growth (yoy) | 39.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -207.03M |
| Net income avi to common (ttm) | -323.99M |
| Diluted EPS (ttm) | -3.8300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 253.92M |
| Total cash per share (mrq) | 2.88 |
| Total debt (mrq) | 478.43M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.80 |
| Book value per share (mrq) | -1.72 |
Cash flow statement
| Operating cash flow (ttm) | -216.58M |
| Levered free cash flow (ttm) | -134.99M |
© 2024 Yahoo. All rights reserved.